KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) FCF Margin (2020 - 2025)

Clover Health Investments (CLOV) has disclosed FCF Margin for 6 consecutive years, with 14.97% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 371.0% year-over-year to 14.97%, compared with a TTM value of 3.61% through Dec 2025, down 951.0%, and an annual FY2025 reading of 3.54%, down 944.0% over the prior year.
  • FCF Margin was 14.97% for Q4 2025 at Clover Health Investments, down from 2.3% in the prior quarter.
  • Across five years, FCF Margin topped out at 14.93% in Q1 2023 and bottomed at 2767.82% in Q4 2023.
  • Average FCF Margin over 5 years is 143.62%, with a median of 5.07% recorded in 2022.
  • The sharpest move saw FCF Margin crashed -274409bps in 2023, then skyrocketed 275655bps in 2024.
  • Year by year, FCF Margin stood at 12.27% in 2021, then crashed by -93bps to 23.73% in 2022, then plummeted by -11566bps to 2767.82% in 2023, then surged by 100bps to 11.26% in 2024, then tumbled by -33bps to 14.97% in 2025.
  • Business Quant data shows FCF Margin for CLOV at 14.97% in Q4 2025, 2.3% in Q3 2025, and 1.0% in Q2 2025.